Clinical trial
Study to Evaluate the Effect of Pasteurized Akkermansia Muciniphila (pAkk) on Complaints Related to Irritable Bowel Syndrome
NCT05348642 is registered in ClinicalTrials.gov with A-Mansia Biotech S.A. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Study to Evaluate the Effect of Pasteurized Akkermansia Muciniphila (pAkk) on Complaints Related to Irritable Bowel Syndrome
- Lead sponsor
- A-Mansia Biotech S.A.
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- July 21, 2022
- Completion date
- January 6, 2023
- Enrollment
- 90 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.